The HKGP, implemented by the Hong Kong Genome Institute (HKGI) and funded by the HKSAR Government, serves as a catalyst for Hong Kong to establish a genome database of the local population.
This database is designed to test infrastructure and talent pool, all of which will facilitate clinical applications of genomic medicine and scientific research to benefit patients.
Congenica was initially appointed for one year to provide tertiary analysis for Whole Genome Sequencing (WGS) based on its ability to support whole genome data analysis at scale.
Since then, Congenica’s AI and automation driven platform has enabled the identification of disease-causing variants in patients who are affected by undiagnosed diseases and hereditary cancer.
Alistair Johnson, chief professional services officer at Congenica, said: “We’re very pleased to be renewing our service contract for an extended two years with HKGI. This is testament not just to the performance of our platform in terms of efficiency and diagnostic yield, but also the customer support and services provided by our team on the ground to help deliver high quality results."
"We look forward to further strengthening our relationship with the team at HKGI and helping them to deliver precise diagnoses and more effective treatments to even more patients across Hong Kong.”